Jessica Craig

FDA issues warning about counterfeit BiCNU

Publish date: May 13, 2016

Publish date: May 12, 2016

Key clinical point: A 2-mg/kg dosage of pembrolizumab given to adult NSCLC patients every 3 weeks is optimal to both reduce tumor size and avoid t...

Publish date: May 11, 2016

Publish date: May 10, 2016

Publish date: May 10, 2016

Key clinical point: Compared with chemotherapy, chemoradiotherapy did not improve survival outcomes in patients with advanced pancreatic cancer. S...

Publish date: May 9, 2016

Publish date: May 9, 2016

Key clinical point: Among those with young-onset CRC, non-Hispanic black patients have lower survival rates than do non-Hispanic white and Hispani...